Biogen
BIIB
#995
Rank
ยฃ13.91 B
Marketcap
ยฃ95.07
Share price
-5.65%
Change (1 day)
-41.72%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ8.73 Billion

According to Biogen's latest financial reports the company's total liabilities are ยฃ8.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Biogen - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ9.03 B-4.48%
2023-12-31ยฃ9.45 B2.44%
2022-12-31ยฃ9.22 B-3.56%
2021-12-31ยฃ9.56 B-6.38%
2020-12-31ยฃ10.22 B-3.54%
2019-12-31ยฃ10.59 B9.74%
2018-12-31ยฃ9.65 B18.06%
2017-12-31ยฃ8.17 B-6.1%
2016-12-31ยฃ8.71 B27.43%
2015-12-31ยฃ6.83 B204.01%
2014-12-31ยฃ2.24 B14.38%
2013-12-31ยฃ1.96 B0.34%
2012-12-31ยฃ1.95 B16.1%
2011-12-31ยฃ1.68 B-1.45%
2010-12-31ยฃ1.71 B20.99%
2009-12-31ยฃ1.41 B-21.59%
2008-12-31ยฃ1.80 B15.86%
2007-12-31ยฃ1.55 B117.47%
2006-12-31ยฃ0.71 B-16.31%
2005-12-31ยฃ0.85 B-29.77%
2004-12-31ยฃ1.21 B-11.05%
2003-12-31ยฃ1.36 B131.22%
2002-12-31ยฃ0.59 B130.8%
2001-12-31ยฃ0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ66.27 B 658.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.64 B 250.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ101.60 B 1,062.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ96.28 B 1,002.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ83.73 B 858.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.20 B-97.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.07 B 404.46%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ2.15 B-75.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.02 B-65.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.11 B-75.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands